Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Semma Therapeutics

Semma Therapeutics
2014 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
$950M LATEST DEAL AMOUNT
13 INVESTORS
Description

Developer of trans-formative therapies designed to eliminate the use of insulin injections for type 1 diabetes patients. The company's trans-formative therapies is a cell-based therapy for diabetes which traditionally requires the use of an invasive insulin pump or multiple daily insulin injections combining proprietary cells with a state-of-the-art device to provide a replacement for the missing beta cells in a diabetic patient without immunosuppression, enabling doctors to provide a functional cure for patients with diabetes.

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 100 Technology Square
  • Floor 3
  • Cambridge, MA 02139
  • United States

+1 (857) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Semma Therapeutics’s full profile, request a free trial.

Semma Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition $950M 00000 00000 Completed Generating Revenue
3. Early Stage VC (Series B) 30-Nov-2017 00000 00000 Completed Startup
2. Grant 12-Sep-2016 $5M $44M Completed Startup
1. Early Stage VC (Series A) 24-Mar-2015 $44M $44M 000.00 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Semma Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
To view this company’s complete Cap Table, request access »

Semma Therapeutics Competitors (41)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ViaCyte Venture Capital-Backed San Diego, CA 00 00000 00000000000 00000
000000000 Formerly VC-backed Tucson, AZ 00 000.00 000000&0 000.00
00000 Venture Capital-Backed Boston, MA 0 0000 000
0000000000 Venture Capital-Backed Abingdon, United Kingdom 000 00000 00000000000 00000
00000 000000000000 Formerly VC-backed New York, NY 00 000.00 000000000000 000.00
To view this company’s complete list of competitors, request access »

Semma Therapeutics Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 16-Nov-2015 000000000000000000 Therapeutic Devices 0000000 000000 00.0
To view this company’s complete investment and acquisition history, request access »

Semma Therapeutics Executive Team (15)

Name Title Board
Seat
Contact
Info
Bastiano Sanna Ph.D Chief Executive Officer & President
Mary Fenton Chief Financial Officer
David DiGiusto Ph.D Chief Technical Officer
Briannan Bintz Director of Delivery
Felicia Pagliuca Ph.D Vice President, Cell Biology and Research & Development and Co-Founder

4 Former Executives

You’re viewing 5 of 15 executives. Get the full list »

Semma Therapeutics Board Members (12)

Name Representing Role Since Contact
Info
Douglas Melton Ph.D Semma Therapeutics Scientific Co-Founder and Board Observer 000 0000
Mark Fishman MD Self Chairman 000 0000

10 Former Board Members

You’re viewing 2 of 12 board members. Get the full list »